Zobrazeno 1 - 10
of 596
pro vyhledávání: '"S B Abramson"'
Autor:
M. Attur, C. M. Petrilli, Ruth Fernandez-Ruiz, S. B. Abramson, Timothy B. Niewold, Jacqueline L. Paredes, Ashira D Blazer, A. Chakravarti, E. Iturrate, T. L. Wampler Muskardin, S. Tuminello, I. Nln
Publikováno v:
medRxiv
article-version (status) pre
article-version (number) 1
Translational Research
article-version (status) pre
article-version (number) 1
Translational Research
Type I interferon (IFN) is critical in our defense against viral infections. Increased type I IFN pathway activation is a genetic risk factor for systemic lupus erythematosus (SLE), and a number of common risk alleles contribute to the high IFN trait
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c49b16c59379d00d89caa7644fc970aa
https://doi.org/10.1101/2021.11.01.21265766
https://doi.org/10.1101/2021.11.01.21265766
Autor:
Wang D; Center of Experimental Orthopaedics, Saarland University and Saarland University Medical Center, Kirrbergerstr. Bldg 37, D-66421, Homburg/Saar, Germany., Liu W; Center of Experimental Orthopaedics, Saarland University and Saarland University Medical Center, Kirrbergerstr. Bldg 37, D-66421, Homburg/Saar, Germany., Venkatesan JK; Center of Experimental Orthopaedics, Saarland University and Saarland University Medical Center, Kirrbergerstr. Bldg 37, D-66421, Homburg/Saar, Germany., Madry H; Center of Experimental Orthopaedics, Saarland University and Saarland University Medical Center, Kirrbergerstr. Bldg 37, D-66421, Homburg/Saar, Germany., Cucchiarini M; Center of Experimental Orthopaedics, Saarland University and Saarland University Medical Center, Kirrbergerstr. Bldg 37, D-66421, Homburg/Saar, Germany.
Publikováno v:
Advanced healthcare materials [Adv Healthc Mater] 2024 Nov 06, pp. e2402737. Date of Electronic Publication: 2024 Nov 06.
Publikováno v:
Molecular Medicine Today. 5:148-151
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc4726c4984dcae8ea22f9b57c4304a1
https://doi.org/10.1016/s1357-4310(99)01452-5
https://doi.org/10.1016/s1357-4310(99)01452-5
Publikováno v:
The Journal of Immunology. 148:2201-2206
We have recently demonstrated that human neutrophils (PMN) possess two different classes of adenosine receptors (A1 and A2) that, when occupied, promote chemotaxis and inhibit the generation of reactive oxygen species (e.g., O2- and H2O2), respective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ca4a491a5441394a19bae6484266096
https://doi.org/10.4049/jimmunol.148.7.2201
https://doi.org/10.4049/jimmunol.148.7.2201
Arachidonic acid as a second messenger. Interactions with a GTP-binding protein of human neutrophils
Publikováno v:
The Journal of Immunology. 147:231-236
Arachidonic acid (20:4) and other cis-unsaturated fatty acids exert direct effects on a variety of cells, effects that do not depend on the metabolism of fatty acids via cyclooxygenase or lipoxygenase pathways. In these studies arachidonic acid and o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40bb11446304622edafb0c594351670d
https://doi.org/10.4049/jimmunol.147.1.231
https://doi.org/10.4049/jimmunol.147.1.231
Publikováno v:
The Journal of Immunology. 144:4757-4764
Cocaine and its derivatives blunted responses of neutrophils (cell/cell aggregation, up-regulation of the receptor for C3bi (CR3, CD11b/CD18), generation of superoxide anion (O2-) and degranulation to various stimuli. The order of potency of these ag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9c00a44ba125e2292c176f3c99caa2a
https://doi.org/10.4049/jimmunol.144.12.4757
https://doi.org/10.4049/jimmunol.144.12.4757
Publikováno v:
The Journal of Immunology. 144:191-197
We sought to determine whether the activation event which renders the CD11/CD18 leukocyte integrin/Leu-CAM glycoproteins capable of promoting cell to cell adhesion was associated with the induced posttranslational modification of phosphorylation. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10225b49994dac10f3ac4e8599d0b93e
https://doi.org/10.4049/jimmunol.144.1.191
https://doi.org/10.4049/jimmunol.144.1.191
Publikováno v:
Clinical and experimental rheumatology. 22(5 Suppl 35)
Targeted tumor necrosis factor-alpha antagonists, first approved by the FDA in 1998, have had a significant impact on the treatment of patients with rheumatoid arthritis. In general, the benefit/ risk ratio for these agents and the IL-1 receptor anta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1431a958c32a553a6a253dd6f8c85a1c
https://pubmed.ncbi.nlm.nih.gov/15552523
https://pubmed.ncbi.nlm.nih.gov/15552523
Autor:
M G, Attur, M N, Dave, K, Tsunoyama, M, Akamatsu, M, Kobori, J, Miki, S B, Abramson, M, Katoh, A R, Amin
Publikováno v:
Current issues in molecular biology. 4(4)
Human and other annotated genome sequences have facilitated generation of vast amounts of correlative data, from human/animal genetics, normal and disease-affected tissues from complex diseases such as arthritis using gene/protein chips and SNP analy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dbb8c90aada41480e91582575626eb79
https://pubmed.ncbi.nlm.nih.gov/12432964
https://pubmed.ncbi.nlm.nih.gov/12432964
Autor:
S B, Abramson
Publikováno v:
Clinical and experimental rheumatology. 19(6 Suppl 25)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fe5f36034c72d4c523c19513b445dea8
https://pubmed.ncbi.nlm.nih.gov/11695245
https://pubmed.ncbi.nlm.nih.gov/11695245